Dr Lawrence Park is a psychiatrist. He has worked at the Experimental Therapeutics and Pathophysiology Branch at NIMH since 2014 and currently serves as medical director of the Clinical Research Unit. In this conversation, we discuss what ketamine is and what we might be able to learn from it about depression, the current state of research into ketamine as a treatment for unipolar and bipolar depression, what it's like when someone receives a ketamine infusion, the problems with ketamine and the questions that are still outstanding. Dr Park also shares with us what it's like to work at the National Institute of Mental Health and future research goals. Interviewed by Dr. Anya BorissovaGive feedback here - [email protected] Follow us here: Twitter @thinkingmindpod Instagram @thinkingmindpodcastSUPPORT THE PODCAST: buymeacoffee.com/thinkingmindGive feedback here - [email protected] Follow us here: Twitter @thinkingmindpod Instagram @thinkingmindpodcast

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.